中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Viral Diseases
NASH/PBC
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
Voluntary Announcement - Gannex Published Phase I Data of ASC42, A Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D
2023-11-06
Next Day Disclosure Returns - Share Buyback
2023-11-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
2023-11-03
Next Day Disclosure Returns - Share Buyback
2023-11-02
Next Day Disclosure Returns - Share Buyback
2023-11-01
Next Day Disclosure Returns - Share Buyback
2023-10-31
Next Day Disclosure Returns - Share Buyback
2023-10-30
Next Day Disclosure Returns - Share Buyback
2023-10-27
Next Day Disclosure Returns - Share Buyback
2023-10-26
Next Day Disclosure Returns - Share Buyback
2023-10-25
«
2
3
4
5
»